| Affiliation: | 1. Department of Respiratory Medicine, G. Papanikolaou Hospital , Thessaloniki, Greece afboutou@yahoo.com;3. Department of Respiratory Failure, Aristotle University of Thessaloniki , Thessaloniki, Greece |
| Abstract: | ABSTRACT Introduction Pulmonary arterial hypertension (PAH) is still a chronic disorder characterized by high morbidity and mortality. Chronic thromboembolic pulmonary hypertension (CTEPH) is another form of pulmonary hypertension (PH) for which pulmonary endarterectomy (PEA) is the treatment of choice. However, not all patients are operable, while PH is often recurrent or persistent. Thus, for both disorders novel treatment options are urgently needed. |
